Northwest Biotherapeutics NWBO
OTC NWBO
$0.17 +0.00 (+0.00%)
At close: Nov 10, 2026 · 4:00 PM EST

Northwest Biotherapeutics (NWBO) Revenue (2009 - 2026)

Updated

Analysis

Northwest Biotherapeutics (NWBO) Revenue (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 24.40 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 25.40 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 17.40 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 18.09 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 15.07 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 10.37 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 8.30 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 16.58 Bn
10 Northwest Biotherapeutics 283.78 Mn 273.80 Mn - 807,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 807,000.00
Mar 31, 2026 494,000.00
Dec 31, 2025 672,000.00
Sep 30, 2025 200,000.00
Jun 30, 2025 131,000.00
Mar 31, 2025 375,000.00
Dec 31, 2024 231,000.00
Sep 30, 2024 357,000.00
Jun 30, 2024 510,000.00
Mar 31, 2024 284,000.00
Dec 31, 2023 445,000.00
Sep 30, 2023 406,000.00
Jun 30, 2023 201,000.00
Mar 31, 2023 880,000.00
Dec 31, 2022 597,000.00
Sep 30, 2022 206,000.00
Jun 30, 2022 477,000.00
Mar 31, 2022 403,000.00
Sep 30, 2021 350,000.00
Jun 30, 2021 416,000.00
API Access

Northwest Biotherapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=NWBO&period=max&api_key=YOUR_API_KEY